Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salvacion Gatchalian

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The American Journal of Tropical Medicine and Hygiene|March 20, 2004
Immunogenicity and safety of a varicella vaccine (Okavax) and a trivalent measles, mumps, and rubella vaccine (Trimovax) administered concomitantly in healthy Filipino children 12-24 months oldSalvacion Gatchalian, Charissa Tabora, Nancy Bermal, et al.
Human Vaccines & Immunotherapeutics|February 15, 2012
A randomized, dose-ranging assessment of the immunogenicity and safety of a booster dose of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B-inactivated poliovirus-Hemophilus influenzae type b (DTPw-HBV-IPV/Hib) vaccine vs. co-administration of DTPw-HBV/Hib and IPV vaccines in 12 to 24 months old Filipino toddlersBeatriz Quiambao, Olivier Van Der Meeren, Devayani Kolhe, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|April 30, 2004
Immunogenicity and safety of a varicella vaccine, Okavax, and a trivalent measles, mumps and rubella vaccine, MMR-II, administered concomitantly in healthy Filipino children aged 12-24 monthsSalvacion Gatchalian, Didier Leboulleux, Eric Desauziers, et al.
The Pediatric Infectious Disease Journal|August 13, 2003
Predictors of neonatal sepsis in developing countriesMartin W Weber, John B Carlin, Salvacion Gatchalian, et al.
Annals of Tropical Paediatrics|October 14, 2004
The use of CRP for diagnosing infections in young infants < 3 months of age in developing countriesAyo Palmer, John B Carlin, Joachim Freihorst, et al.
Human Vaccines|April 1, 2008
A new DTPw-HBV/Hib vaccine: immune memory after primary vaccination and booster dosing in the second year of lifeSalvacion Gatchalian, Marietta Reyes, Nancy Bermal, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 4, 2003
Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccineJavier Arístegui, Vytautas Usonis, Hoosen Coovadia, et al.
The Pediatric Infectious Disease Journal|March 28, 2009
The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicityNancy Bermal, Leszek Szenborn, Andrzej Chrobot, et al.
Vaccine|April 9, 2008
Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infantsSalvacion Gatchalian, Yafu Yao, Benli Zhou, et al.
The Pediatric Infectious Disease Journal|April 26, 2017
Safety of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children: An Open-label, Randomized, Active-controlled, Phase 3 StudyKatrin L Dubischar, Vera Kadlecek, Benjamin Sablan, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The American Journal of Tropical Medicine and Hygiene|March 20, 2004
Immunogenicity and safety of a varicella vaccine (Okavax) and a trivalent measles, mumps, and rubella vaccine (Trimovax) administered concomitantly in healthy Filipino children 12-24 months oldSalvacion Gatchalian, Charissa Tabora, Nancy Bermal, et al.
Human Vaccines & Immunotherapeutics|February 15, 2012
A randomized, dose-ranging assessment of the immunogenicity and safety of a booster dose of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B-inactivated poliovirus-Hemophilus influenzae type b (DTPw-HBV-IPV/Hib) vaccine vs. co-administration of DTPw-HBV/Hib and IPV vaccines in 12 to 24 months old Filipino toddlersBeatriz Quiambao, Olivier Van Der Meeren, Devayani Kolhe, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|April 30, 2004
Immunogenicity and safety of a varicella vaccine, Okavax, and a trivalent measles, mumps and rubella vaccine, MMR-II, administered concomitantly in healthy Filipino children aged 12-24 monthsSalvacion Gatchalian, Didier Leboulleux, Eric Desauziers, et al.
The Pediatric Infectious Disease Journal|August 13, 2003
Predictors of neonatal sepsis in developing countriesMartin W Weber, John B Carlin, Salvacion Gatchalian, et al.
Annals of Tropical Paediatrics|October 14, 2004
The use of CRP for diagnosing infections in young infants < 3 months of age in developing countriesAyo Palmer, John B Carlin, Joachim Freihorst, et al.
Human Vaccines|April 1, 2008
A new DTPw-HBV/Hib vaccine: immune memory after primary vaccination and booster dosing in the second year of lifeSalvacion Gatchalian, Marietta Reyes, Nancy Bermal, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 4, 2003
Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccineJavier Arístegui, Vytautas Usonis, Hoosen Coovadia, et al.
The Pediatric Infectious Disease Journal|March 28, 2009
The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicityNancy Bermal, Leszek Szenborn, Andrzej Chrobot, et al.
Vaccine|April 9, 2008
Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infantsSalvacion Gatchalian, Yafu Yao, Benli Zhou, et al.
The Pediatric Infectious Disease Journal|April 26, 2017
Safety of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children: An Open-label, Randomized, Active-controlled, Phase 3 StudyKatrin L Dubischar, Vera Kadlecek, Benjamin Sablan, et al.
Pageof 2